Ethics, pharmacy, policy and pediatric cancer experts publish recommendations for managing and preventing drug shortages
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
In a consensus statement published in the journal Pediatrics, the experts say they sought to move away from the current strategy of reaction to shortages once they have occurred and focus instead on prevention. Using the example of shortages of chemotherapy drugs used for treating children with cancer—therapies proven to have high survival rates for the most common childhood cancers—the group developed “a comprehensive blueprint for action” they say is critical for managing and preventing future drug shortages.
“Although our recommendations were developed with pediatric oncology in mind, and serve as a blueprint for preventing children with cancer from lacking access to essential life-saving medications, we believe that they apply more broadly across medicine to include pediatrics and adult medicine in general,” says Yoram Unguru, a pediatric hematologist/oncologist at the Herman and Walter Samuelson Children’s Hospital at Sinai and faculty member at the Johns Hopkins Berman Institute of Bioethics. Unguru, a coauthor of the consensus statement, was the principal organizer of meetings that led to its creation, bringing together representatives from the Food and Drug Administration (FDA), leadership of the Children’s Oncology Group and The American Society of Pediatric Hematology/Oncology, patient advocacy groups, legal scholars and clinicians.
Some recommendations would represent new norms for healthcare practice, including the sharing of scarce drugs between healthcare institutions and not giving preferential access to patients participating in research studies.
“This statement is significant both for the consensus found by such a diverse group of experts, and for being the first to take seriously the ethical rationale to prevent shortages in the first place,” says Matthew DeCamp, a Johns Hopkins professor at the Berman Institute of Bioethics and Division of General Internal Medicine, and lead author of the consensus statement.
Included in the statement’s six recommendations is a call to develop policies that give equal priority to patients regardless of whether they are participants in research. The authors acknowledge this “may be controversial,” due to the sentiment that fairness requires giving research participants high-priority access to drugs because of their contribution to medical knowledge and future patients. However, the statement’s authors explain that “concerns over undue inducement, public perception, and the imperative to use drugs for indications for which evidence of benefit exists outweigh arguments for giving priority access to research participants.”
For each recommendation the statement also includes potential barriers to its implementation. A centralized information source of drug supply information, for instance, faces the risk that such information will encourage hoarding of existing supplies, including so-called “gray market” suppliers that sell scarce drugs for inflated prices. The statement calls for new policies for both reporting and avoiding these markets, though acknowledges the temptation of healthcare providers to use them in a shortage, when their patients are in need.
The Latest on: Shortages of life-saving drugs
via Google News
The Latest on: Shortages of life-saving drugs
- Now drug for ‘black fungus’ is in short supplyon May 15, 2021 at 7:12 pm
The most commonly prescribed medicine for mucormycosis, Liposomal Amphotericin B, is in short supply in Karnataka. Trader and activist Sajjan Raj Mehta said there were nearly 20 patients in urgent ...
- Now, life-saving injection to treat ‘black fungus’ out of stock in Lucknowon May 15, 2021 at 12:21 pm
As cases of black fungal infection, a post-Covid complication, are being reported from all across Uttar Pradesh, including the state capital, the Liposomal Amphotericin B injection, used in treating t ...
- No oxygen shortage in Telangana: DME Ramesh Reddyon May 13, 2021 at 5:40 pm
Nearly 100 ventilators will soon be repaired and deployed for use, said Director of Medical Education Dr K Ramesh Reddy at a press meet on Thursday.
- MRP violations of essential drugs in Hyderabad under Legal Metrology scanneron May 13, 2021 at 5:13 pm
HYDERABAD: As the Covid-19 second wave has led to a shortage of medicines and health monitoring tools, the Legal Metrology Department has been keeping a close eye on medical distributors and traders ...
- High demand leads to shortage of key drug to treat Black Funguson May 13, 2021 at 10:23 am
An exponential growth in demand for Liposomal Amphotericin B amid more people contracting Mucormycosis has resulted in an acute shortage of the key, expensive drug used in the treatment of the rare ...
- Tamil Nadu faces acute shortage of Remdesivir vialson May 11, 2021 at 5:16 pm
Amid a shortage of the antiviral drug, it is being reported that there is an acute shortage of Remdesivir in Tamil Nadu. Family members of COVID patients are waiting in long queues without assurance ...
- India's COVID crisis spawns black market for oxygen, drugson May 11, 2021 at 7:09 am
As patients struggle to find available hospital beds, life-saving drugs and medical oxygen, a flourishing black market is fleecing hapless people across the country.
- Avoid Over-reliance on Foreign Drugs in Covid-19 Treatment: Bombay High Courton May 7, 2021 at 11:44 pm
Stating that over-reliance on imported drugs must be avoided, the Bombay High Court has asked the Centre and the Maharashtra government to create awareness about suitable alternatives to ...
- Is Gujarat hoarding the life-saving drug Remdesivir amongst shortage in the country? | Frankly Speakingon May 6, 2021 at 9:30 pm
In this episode of Frankly Speaking, Gujarat CM Vijay Rupani puts forth his opinion on the current COVID crisis and the strategies that the Gujarat government is putting in place in order to combat ...
- Can't Ascertain Oxygen Shortage As Cause Of Death At Jaipur Golden Hospital: Delhi Governmenton May 4, 2021 at 2:51 am
The Delhi government has informed the Delhi High Court that oxygen shortage as the cause of death of 21 COVID-19 patients at Jaipur Golden Hospital in the city could not be ascertained by an expert ...
via Bing News